PFE Pfizer Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

PFE [NYSE]

Pfizer Inc.

Healthcare | Drug Manufacturers - General | USA

statements

Index	S&P 500	P/E	14.91	EPS (ttm)	2.46	Insider Own	0.04%	Shs Outstand	5.55B	Perf Week	1.55%
Market Cap	204.60B	Forward P/E	10.92	EPS next Y	3.35	Insider Trans	-7.21%	Shs Float	5.55B	Perf Month	-4.26%
Income	13.85B	PEG	2.78	EPS next Q	0.72	Inst Own	72.00%	Short Float	0.81%	Perf Quarter	9.61%
Sales	49.20B	P/S	4.16	EPS this Y	62.30%	Inst Trans	-1.45%	Short Ratio	1.60	Perf Half Y	26.27%
Book/sh	11.58	P/B	3.16	EPS next Y	14.47%	ROA	8.30%	Target Price	41.79	Perf Year	0.33%
Cash/sh	2.04	P/C	17.98	EPS next 5Y	5.37%	ROE	22.00%	52W Range	27.88 - 40.97	Perf YTD	-6.51%
Dividend	1.52	P/FCF	44.72	EPS past 5Y	14.70%	ROI	14.70%	52W High	-10.59%	Beta	0.66
Dividend %	4.15%	Quick Ratio	1.20	Sales past 5Y	0.90%	Gross Margin	80.40%	52W Low	31.38%	ATR	0.70
Employees	88300	Current Ratio	1.40	Sales Q/Q	-11.00%	Oper. Margin	31.10%	RSI (14)	42.66	Volatility	1.81% 1.92%
Optionable	Yes	Debt/Eq	0.99	EPS Q/Q	-31.50%	Profit Margin	28.80%	Rel Volume	1.06	Prev Close	36.82
Shortable	Yes	LT Debt/Eq	0.79	Earnings	Jul 28 BMO	Payout	57.90%	Avg Volume	28.19M	Price	36.63
Recom	2.50	SMA20	-1.62%	SMA50	-1.98%	SMA200	0.40%	Volume	29,992,833	Change	-0.52%

Jun-16-20

Initiated

SVB Leerink

Mkt Perform

$40

Feb-27-20

Upgrade

Standpoint Research

Hold → Buy

Feb-27-20

Initiated

Barclays

Equal Weight

$36

Feb-06-20

Initiated

Mizuho

Buy

Jan-07-20

Initiated

RBC Capital Mkts

Outperform

$46

Oct-17-19

Resumed

BofA/Merrill

Neutral

$37

Jul-30-19

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$48 → $40

Jul-30-19

Downgrade

BofA/Merrill

Buy → Neutral

Jun-04-19

Resumed

Morgan Stanley

Overweight

$48

Feb-20-19

Resumed

Citigroup

Neutral

$41

Jan-31-19

Upgrade

Credit Suisse

Neutral → Outperform

Jan-31-19

Upgrade

Argus

Hold → Buy

Jan-23-19

Downgrade

UBS

Buy → Neutral

Dec-11-18

Downgrade

JP Morgan

Overweight → Neutral

Nov-01-18

Downgrade

BMO Capital Markets

Outperform → Market Perform

Jun-08-18

Initiated

Cantor Fitzgerald

Overweight

$45

Apr-05-18

Downgrade

Barclays

Overweight → Equal Weight

$41 → $38

Jan-29-18

Reiterated

SunTrust

Hold

$33 → $40

Sep-20-17

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Jul-20-17

Downgrade

Credit Suisse

Outperform → Neutral

Sep-20-20 08:23AM	3 Biotech Stocks Poised For Massive Future Growth Insider Monkey
06:09AM	3 Best Coronavirus Vaccine Stocks to Buy Right Now Motley Fool
Sep-18-20 07:13PM	Is Pfizer Stock a Buy Right Now? This Is What You Need to Know TipRanks
06:05PM	Bristol Myers' Opdivo with Exelixis drug cuts kidney cancer death risk -study Reuters
04:44PM	We have to continue to be really, really vigilant in maintaining our health infrastructure: Dr. Amesh Adalja Yahoo Finance Video
04:25PM	Johnson & Johnson stock outperforms competitors on strong trading day MarketWatch
03:57PM	EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.? Reuters
03:12PM	Three-quarters of Americans are worried about the vaccine rush: Pew Yahoo Finance Video
02:36PM	Novavax Stock Is a Risky Way to Get Rich Quick InvestorPlace
01:58PM	iBio Is a Wishful Thinkers Coronavirus Vaccine Bet InvestorPlace
11:12AM	EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.? Reuters
10:20AM	Unusual Options Activity Insight: Pfizer Benzinga
09:51AM	Why Novartis Absence From the Covid-19 Vaccine Race Is a Benefit InvestorPlace
09:26AM	Is Sorrento Stock Really Worth the Speculation? InvestorPlace
09:26AM	Moderna CEO downplays vaccine timeline pressure: 'We don't want the first, we want the best' Yahoo Finance
06:10AM	3 Dividend Stocks Perfect for Retirees Motley Fool
06:08AM	3 Coronavirus Vaccines in Phase 3 Clinical Studies: How They Stack Up Against Each Other Motley Fool
05:46AM	BioNTech Investor Fortunes Rise and Fall on Headlines, Pacts and Funding InvestorPlace
Sep-17-20 10:08PM	Pfizer vaccine trial bets on early win against coronavirus, documents show Reuters
05:48PM	EXPLAINER-When will COVID-19 vaccines be generally available in the U.S.? Reuters
05:23PM	Moderna Shares the Latest on its Coronavirus Vaccine Trial and Other Research Advances Barrons.com
05:02PM	Economic recovery wont come until we get Americans to feel safe: Ric Edelman Yahoo Finance Video
04:54PM	Infectious Diseases Physician on COVID-19 vaccine outlook: 'Its less about whats the exact date, but making sure its effective' Yahoo Finance Video
04:25PM	Johnson & Johnson stock underperforms Thursday when compared to competitors MarketWatch
04:20PM	BioNTech Buys a Plant to Manufacture Its Coronavirus Vaccine Motley Fool
04:16PM	Moderna Updates Progress On Covid-19 Vaccine, Eyes Flu Vaccine Investor's Business Daily
03:29PM	FOCUS-Pfizer vaccine trial bets on early win against coronavirus, documents show Reuters
11:06AM	Race for a COVID-19 vaccine continues, here's what you need to know Yahoo Finance Video
11:00AM	Coronavirus update: Vaccine makers ramp up manufacturing as Trump stirs debate; NYC to delay school reopen Yahoo Finance
08:08AM	3 Reasons Why You Probably Won't Receive a Coronavirus Vaccine Shot by the End of 2020 Motley Fool
07:22AM	Moderna to seek limited emergency use of COVID-19 vaccine if data shows high efficacy Reuters
07:00AM	Moderna would seek limited emergency use of COVID-19 vaccine based on early data Reuters
06:05AM	Here's the Company That Bill Gates Thinks Is the Clear Coronavirus Vaccine Leader Motley Fool
Sep-16-20 04:43PM	U.S. Cases Rise 0.4%; Californias Outbreak Easing: Virus Update Bloomberg
04:25PM	Johnson & Johnson stock falls Wednesday, still outperforms market MarketWatch
03:54PM	Coronavirus Vaccine Trial Adverse Event Was Probably Unrelated to Treatment Motley Fool
02:04PM	Cos. with a real vaccine history will have their data sets in early 2021: Expert Yahoo Finance Video
01:57PM	Lilly and Pfizer Are Testing Treatments for Hospitalized Covid Patients Barrons.com
12:57PM	Coronavirus update: Operation Warp Speed readies for vaccine as CDC tries to manage expectations Yahoo Finance
10:29AM	How Pfizer Plans to Lead the Industry in Gene Therapies Barrons.com
08:33AM	This 3-Stock Portfolio Is a Safe Bet on a Coronavirus Vaccine Motley Fool
08:00AM	Pfizer Says Its Covid Vaccine Is Just the First in a New Wave of Preventives Barrons.com
06:36AM	Turkey begins Phase III trials of Chinese coronavirus vaccine - media Reuters
03:05AM	Pfizer Says COVID-19 Vaccine Only Showed Moderate Side-Effects In Initial Late-Stage Trials Benzinga
01:12AM	Philippines says engaging Western pharma firms, despite Duterte anger Reuters
Sep-15-20 10:33PM	Pfizer says late-stage coronavirus vaccine study shows moderate side effects Reuters
04:27PM	Covid Roundup: BioNTech Boosts Funding; Novavax Boosts Manufacturing Investor's Business Daily
04:16PM	Analyst Report: Pfizer Inc. Morningstar Research
03:49PM	Coronavirus update: Trump says vaccine ready within weeks; Pfizer says some patients show side effects Yahoo Finance
01:56PM	We need a vaccine that's medically effective & trusted: Doctor Yahoo Finance Video
01:31PM	Germany Awards $743 Million to BioNTech and CureVac for Coronavirus Vaccine Development Motley Fool
11:10AM	Pfizer, Novavax, and Other Covid-19 Vaccine Rivals Race Down the Home Stretch. What to Know. Barrons.com
10:52AM	Morning Bell With Jim Cramer: Amazon and Nvidia Are Growing TheStreet.com
09:25AM	Pfizer Highlights Dozens of Drugs in Its Pipeline. Heres What It Means for the Stock. Barrons.com
09:05AM	Opko Shares Climb on Phase 2 Trial of Coronavirus Treatment TheStreet.com
07:00AM	Novavax aims for 2 bln COVID-19 vaccine doses with expanded Serum Institute deal Reuters
06:30AM	BioNTech wins $445 mln German grant for COVID-19 vaccine Reuters
12:15AM	FOREX-Dollar softer on improved risk appetite, yuan soars Reuters
Sep-14-20 09:05PM	FOREX-Dollar softer as sentiment recovers on vaccine hopes and deals Reuters
04:39PM	Seattle Genetics Pact With Drug Giant Merck Sends SGEN Stock Soaring Investor's Business Daily
04:34PM	US STOCKS-Wall Street closes broadly higher on deal news, vaccine hopes Reuters
04:27PM	Covid Roundup: Pfizer Widens Test; AstraZeneca Resumes Late-Stage Trial Investor's Business Daily
04:23PM	Gilead, Pfizer, Eli Lilly CEOs On COVID-19 Treatments, Vaccine Development Benzinga
04:15PM	GLOBAL MARKETS-Stocks rally as COVID-19 vaccines lift hope, dollar eases Reuters
04:00PM	US STOCKS-Wall Street closes broadly higher on deal news, vaccine hopes Reuters
03:38PM	Coronavirus Latest: Monday, September 14 Yahoo Finance Video
03:16PM	GLOBAL MARKETS-COVID-19 vaccine hopes lift world stocks, dollar eases Reuters
03:13PM	Nasdaq Jumps 200 Points In Key Test Of Support; DraftKings Breaks Out; 2 Gold Stocks To Watch Investor's Business Daily
02:05PM	Pfizer Says It Could Know If Its COVID-19 Vaccine Candidate Works in October Motley Fool
01:56PM	Philippines to prioritise coronavirus vaccine supply from Russia or China Reuters
12:48PM	US STOCKS-Wall Street climbs on mega mergers, vaccine hopes Reuters
12:48PM	Coronavirus update: AstraZeneca resumes vaccine trial as Gilead drug gets a boost from Lilly Yahoo Finance
12:12PM	Pfizer Poised for Drop After 31% Rally Amid Covid Vaccine Push Bloomberg
11:59AM	GLOBAL MARKETS-COVID-19 vaccine hopes lift world stocks, dollar eases Reuters
11:58AM	AstraZeneca resumes COVID-19 vaccine trial Yahoo Finance Video
11:19AM	US STOCKS-Wall Street climbs on mega mergers, vaccine hopes Reuters
10:23AM	Vaxart Cleared for Phase 1 Trial of Oral Virus Vaccine Candidate TheStreet.com
10:22AM	US STOCKS-Wall Street climbs on merger deals, vaccine hopes Reuters
09:50AM	ROCE Insights For Pfizer Benzinga
09:41AM	Is Pfizer Inc. (NYSE:PFE) Trading At A 29% Discount? Simply Wall St.
08:47AM	US STOCKS-Wall Street set for higher open on M&A activity, vaccine hopes Reuters
07:40AM	Adobe, FedEx, Lennar and Other Stocks to Watch This Week Barrons.com
06:49AM	US STOCKS-Futures lifted by M&A activity, vaccine hopes Reuters
Sep-13-20 10:56PM	Dollar Edges Lower; Sterling Rebounds After Sharp Selloff Investing.com
10:21PM	Pfizer Seeks FDA Nod To Expand Late-Stage COVID-19 Vaccine Trial Benzinga
08:11PM	Oracle Chosen as Winner in TikTok Sale Barrons.com
05:26PM	Pfizer CEO: Coronavirus vaccine could be distributed in U.S. by end of year MarketWatch
12:52PM	Pfizer and BioNTech Plan to Increase Size of Their Coronavirus Vaccine Clinical Trial Motley Fool
09:04AM	The Surefire Vaccine Winner Following AstraZeneca's COVID-19 Trial Pause Motley Fool
07:12AM	Pfizer, BioNTech Propose Expansion Of Phase 3 Covid-19 Vaccine Trial SmarterAnalyst
06:45AM	What If More Than One Company Wins the Coronavirus Vaccine Race? Motley Fool
06:08AM	3 Best Coronavirus Stocks to Watch in September Motley Fool
Sep-12-20 04:52PM	How The DJIA Can Be Managed For A Wide Range Of Values Insider Monkey
10:45AM	Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial Business Wire
Sep-11-20 11:51AM	Where COVID-19 vaccines stand following AstraZeneca setback Yahoo Finance Video
11:47AM	Vaccine race continues, but roll out raises concerns Yahoo Finance Video
10:00AM	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire
10:00AM	Its Likely Too Late for Regenerons Virus Treatment Barrons.com
09:14AM	Pharma Stock Roundup: AZN & PFE's Coronavirus Vaccine Updates & FDA Approvals Zacks
02:48AM	Philippine health ministry says no conditions set to access U.S. vaccines Reuters

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, such as cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; oncology, such as biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company and Astellas Pharma US, Inc.; licensing agreement with Akcea Therapeutics, Inc; strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; material transfer and collaboration agreement with BioNTech SE to co-develop COVID-19 vaccine; clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; and research collaboration and license agreement with BioInvent International AB. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BLAYLOCK RONALD E	Director	Aug 06	Buy	38.55	13,000	501,085	13,000	Aug 10 08:07 AM
DAMICO JENNIFER B.	SVP & Controller	Jun 05	Sale	36.13	2,181	78,800	7,542	Jun 08 04:29 PM
Dolsten Mikael	President R&D	May 18	Sale	37.78	95,353	3,602,681	174,918	May 19 05:37 PM
DAMICO JENNIFER B.	SVP & Controller	Apr 29	Sale	38.35	2,181	83,641	9,647	May 01 03:56 PM
JOHNSON RADY A	Executive Vice President	Apr 29	Sale	38.36	13,125	503,475	63,940	May 01 03:56 PM
ROGERS DAWN	Executive Vice President	Apr 29	Sale	38.13	13,000	495,690	4,823	May 01 03:56 PM
LANKLER DOUGLAS M	Executive Vice President	Apr 29	Sale	37.85	65,000	2,460,372	78,276	May 01 03:56 PM
PFIZER INC	10% Owner	Mar 16	Buy	16.00	312,500	5,000,000	1,481,719	Mar 16 07:15 PM
GOETTLER MICHAEL	Group President	Feb 28	Option Exercise	27.37	22,852	625,459	53,036	Mar 03 12:54 PM
JOHNSON RADY A	Executive Vice President	Feb 28	Option Exercise	27.37	15,996	437,811	87,956	Mar 03 12:54 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 28	Option Exercise	27.37	38,848	1,063,270	172,542	Mar 03 12:54 PM
MACKENZIE ALEXANDER R	Executive Vice President	Feb 28	Option Exercise	27.37	37,934	1,038,254	140,256	Mar 03 12:54 PM
ROGERS DAWN	Executive Vice President	Feb 28	Option Exercise	27.37	17,824	487,843	30,045	Mar 03 12:54 PM
SUSMAN SALLY	Executive Vice President	Feb 28	Option Exercise	27.37	91,408	2,501,837	222,496	Mar 03 12:55 PM
YOUNG JOHN D	Group President	Feb 28	Option Exercise	27.37	100,548	2,751,999	504,427	Mar 03 12:55 PM
BOURLA ALBERT	Chairman & CEO	Feb 28	Option Exercise	27.37	33,135	906,905	232,888	Mar 03 12:49 PM
CANGIALOSI LORETTA V	Sr. Vice President, Controller	Feb 28	Option Exercise	27.37	27,422	750,540	140,744	Mar 03 12:49 PM
DAMELIO FRANK A	Executive Vice President	Feb 28	Option Exercise	27.37	173,675	4,753,485	556,084	Mar 03 12:49 PM
YOUNG JOHN D	Group President	Feb 26	Option Exercise	34.59	144,928	5,013,060	503,738	Feb 28 07:32 PM
ROGERS DAWN	Executive Vice President	Feb 26	Option Exercise	34.59	15,097	522,205	24,995	Feb 28 07:28 PM
SUSMAN SALLY	Executive Vice President	Feb 26	Option Exercise	34.59	72,464	2,506,530	180,558	Feb 28 07:28 PM
JOHNSON RADY A	Executive Vice President	Feb 26	Option Exercise	34.59	33,414	1,155,790	93,211	Feb 28 07:24 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 26	Option Exercise	34.59	88,567	3,063,533	189,936	Feb 28 07:25 PM
GOETTLER MICHAEL	Group President	Feb 26	Option Exercise	34.59	20,129	696,262	45,557	Feb 28 07:22 PM
Hwang Angela	Group President	Feb 26	Option Exercise	34.59	14,493	501,313	32,470	Feb 28 07:22 PM
DAMELIO FRANK A	Executive Vice President	Feb 26	Option Exercise	34.59	144,928	5,013,060	482,320	Feb 28 07:19 PM
BOURLA ALBERT	Chairman & CEO	Feb 26	Option Exercise	34.59	88,567	3,063,533	274,479	Feb 28 07:16 PM
CANGIALOSI LORETTA V	Sr. Vice President, Controller	Feb 26	Option Exercise	34.59	24,155	835,521	131,196	Feb 28 07:15 PM
Gottlieb Scott	Director	Jan 30	Buy	37.00	1,000	36,997	4,000	Jan 31 08:06 AM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience